Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Released Nov 12, 2019, after the close
10-Q filed Nov 12, 2019, 43 days after period end · 0001104659-19-062594
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $183.06K | — |
| Net Income | -$5.46M | -$4.39M | -$3.99M | -$2.10M |
| EPS Diluted |
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.32 |
| -$0.39 |
| -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
